Pharmaceuticals and Biotech | Media Room

Press Release Mar 11, 2022

Evidence of Manipulated Lyme Disease Diagnostics Presented to Suffolk County, NY Health Commissioner

Nonprofit Group Seeks Remedy for Decades of Inaccurate Lyme Disease Testing Read More

Press Release Mar 7, 2022

Dr. Gerard Blobe, M.D., Ph.D., Joins Vivacitas Oncology's Solid Tumor Medical Advisory Board

Press Release Mar 4, 2022

CDMOs Recognized for Service and Leadership

Pharma and biotech customers select service providers for excellence in capabilities, expertise, quality, compatibility, reliability, and service Read More

Press Release Mar 3, 2022

OliLux Biosciences Kickstarts a Partnership With the UCSF Center for Tuberculosis and the Rapid Research in Diagnostics Development (R2D2) for TB Network

OliLux Biosciences is partnering with the R2D2 TB Network and the UCSF Center for Tuberculosis to clinically evaluate and advance its novel rapid detection technology for drug-resistant tuberculosis. Read More

Press Release Mar 2, 2022

Sensus Healthcare Sells Its Sculptura™ Assets to Empyrean Medical Systems for $15 Million in Cash

Sale permits Sensus to focus on the core dermatology market while providing capital for channel expansion Read More

Press Release Feb 28, 2022

Ferrer Announces Distribution Agreement With United Therapeutics for Treprostinil Inhalation Solution for Pulmonary Hypertension Associated With Interstitial Lung Disease

PH-ILD is a rare, serious, and progressive illness without an approved treatment in Europe and many other parts of the world Read More

Press Release Feb 23, 2022

Scailyte Hosts Webinar About Supervised Learning of Disease-Associated Cell States and Dynamics

Webinar on the latest developments in the analysis of single-cell data, including from transcriptomic and imaging technologies. Read More

Press Release Feb 21, 2022

Stanislaus County to Conduct First-Ever Online Tax Sale on Bid4Assets

The online auction will open March 7 with 40 properties listed. Read More

Press Release Feb 17, 2022

Bob Discordia Joins CaaMTech as Chief Scientific Officer

Dr. Discordia brings over 30 years of pharmaceutical industry experience to CaaMTech Read More

Press Release Feb 17, 2022

Philogen Receives Authorisation to Initiate New Study in France to Evaluate Nidlegy™ in Several Non-Melanoma Skin Cancers

Press Release Feb 16, 2022

K3-Innovations Has Retained Biopharmaceutical Development Veteran Jim Baker to Drive Expansion of Its Clinical Research Offerings

Press Release Feb 14, 2022

Vivacitas Oncology to Present at the 2022 BIO CEO & Investor Conference

Press Release Feb 7, 2022

Nemysis Ltd Announces Appointment of Antonino Santoro as Adviser for Scientific Affairs

Press Release Feb 3, 2022

Nexien BioPharma Engages Dr. Benedikt Schoser as Advisor

Press Release Feb 1, 2022

Gb Sciences and Michigan State University Researchers Have Identified the Complicated Truth Behind the Opportunity for an Effective Cannabinoid-Based Coronavirus Treatment

Gb Sciences' collaboration with MSU has received media coverage across the country, starting with an interview from WLNS-TV in Lansing, Michigan, and interviews with Gb Sciences in the magazines 'Cannabis Business Times' and 'Hemp Grower' Read More

Press Release Jan 31, 2022

Vivacitas Oncology Strengthens Its Neuro-Oncology Board With World-Class Advisor Dr. Katherine Peters, MD, PhD, FAAN

Press Release Jan 25, 2022

Premier Pharmacy Services Adds KRYSTEXXA® (Pegloticase) to Rare Disease Portfolio

Press Release Jan 24, 2022

Explora BioLabs Launches Preclinical Vivarium Model in Seattle

Turnkey research facilities expand national network, opens new market Read More

Press Release Jan 24, 2022

Atrial Fibrilillation Study by NativeCardio and the Texas Heart Institute Show Ultra-Low Cardioversion is Possible

Press Release Jan 24, 2022

Cellvera Receives $20M Purchase Order for COVID-19 Oral Antiviral Avigan®

Press Release Jan 21, 2022

AiPharma Announces Corporate Rebrand, Changing Its Name to Cellvera

Cellvera unveils new logo and corporate identity as part of the extensive rebranding initiative Read More

Press Release Jan 18, 2022

Vivacitas Oncology to Present a Poster on AR-67 at the 3rd Annual Glioblastoma Drug Development Summit

Press Release Jan 17, 2022

Dr. Erkut Borazanci, MD, Joins Vivacitas Oncology's Pancreatic Medical Advisory Board

Press Release Jan 12, 2022

Craig Darling Joins Virgo Surgical Video Solutions

Twenty-Year Life Sciences Commercial Leader joins Virgo to Scale Clinical Trial Acceleration Platform Read More

Press Release Jan 11, 2022

FDA Pre-Submission Filed for Cardio inCode-SCORE

Commencement of regulatory pathway for U.S. market approval Read More

Press Release Jan 10, 2022

Vivacitas Oncology to Present AR-67 at the Biotech Showcase Investor Conference

Press Release Jan 10, 2022

Shauna Aherne Appointed New President of MedEvoke

Press Release Jan 10, 2022

Halo Biosciences Participating in BIO @ JPM and BIOTECH SHOWCASE™ During J.P. Morgan Week 2022

Press Release Jan 10, 2022

Scailyte Closes Financing Round and Onboards Top Biotech Leaders to Prepare for Growth in 2022

First closing of Series A round and onboarding of top biotech leaders to fuel growth in 2022 Read More

Press Release Jan 7, 2022

Enalare Files Additional Patent Application for Lead Compound ENA-001 - Enhancing Potential Global Exclusivity Through 2042

Press Release Jan 3, 2022

Vivacitas Oncology Welcomes Dr. Jai Grewal, MD, and Expands Its Neuro-Oncology Advisory Board

Press Release Dec 28, 2021

Enalare Therapeutics Invited to Present at Upcoming Biotech Conferences

H.C. Wainwright Bioconnect Conference - Jan. 10, 2022; Biotech Showcase 2022 Conference - Jan. 10, 2022 Read More

Press Release Dec 22, 2021

Qualer Has Added New Automation Software Features for Their Asset Maintenance Software Solutions

Press Release Dec 15, 2021

Hyris Fully Embraces the Immunology Sector to Better Fight COVID-19 and Beyond, Presenting Its New, Disruptive T-Cell Test to the International Conference 'A-Wish'

Hyris is going to present its new test to detect the body's T Cell immune response to SARS-CoV-2 on 17 December 2021, at "A-WISH", Alicante-Winter Immunology Symposium in Health, which will address strategies for the COVID-19 response and the development of the vaccines against SARS-CoV-2. This new solution leverages the Hyris System™, a proprietary platform that enables genetic testing in any setting, at any time, with results available in real-time through its AI-powered platform. Read More

Press Release Dec 14, 2021

Enalare Therapeutics Receives Rare Pediatric Disease Designation for Lead Compound ENA-001 for the Treatment of Apnea of Prematurity

Press Release Dec 13, 2021

Courier Health Named One of the Most Innovative Startups of 2021 by PM360

Press Release Nov 30, 2021

Vivacitas Oncology Announces Additions to Leadership Team and Board

Press Release Nov 30, 2021

Enalare Therapeutics Files New Patent Application for Lead Product ENA-001 - Potentially Extending Global Exclusivity Through 2042

Press Release Nov 22, 2021

Vivacitas Oncology, Inc. to Present on AR-67 at the Annual 5th Meridian Clinical Trials Conference

Press Release Nov 16, 2021

CaaMTech Teams Up With University of Wyoming to Study Psychedelics as Treatments for Addiction

Scientists will assess the potential of psychedelic compounds for treating addiction Read More

Press Release Nov 16, 2021

InDevR Launches ArrayMax Mixer for Even Faster VaxArray Assay Times

Press Release Nov 8, 2021

Swiss Life Sciences Group Opens Funding Platform for the CBD Industry

Swiss Life Sciences Group Plc (SLSG) has identified a need in the fast-growing cannabis and CBD industry to establish a financing and credit facility for companies and brands, especially those in the medical and pharmaceutical sector. Read More

Press Release Nov 4, 2021

Enalare Therapeutics Announces First Subject Dosed With Lead Product ENA-001 in a Propofol-Induced Respiratory Depression Study

Press Release Nov 2, 2021

Sambrosa, Manufacturer of Herbal-Based, Allergy Nighttime Syrup, Hosts New 'Sambrosa vs. Competitors' Challenge to Prove Their Reputation

Sambrosa is going head to head with competitors to uphold and defend their title of having the best allergy decongestant Read More

Press Release Nov 2, 2021

Enalare Therapeutics Invited to Present at BARDA Industry Day 2021

Press Release Nov 2, 2021

Philogen SpA - Notice of Q3 Results

Press Release Nov 1, 2021

Premier Pharmacy Services Adds UPLIZNA® (Inebilizumab-Cdon) to Rare Disease Portfolio

Press Release Nov 1, 2021

Gb Sciences Starts Preclinical Study for Plant-Based Formulas to Treat Depression and Anxiety

The biopharma technology company's AI-driven PhAROS™ platform has identified novel, plant-inspired formulations that will be tested using preclinical Zebrafish models at the National Research Council of Canada. Read More

Press Release Oct 26, 2021

RIVANNA announces award from U.S. government to develop Accuro Platform for rapid triage of blast-related injuries

Press Release Oct 26, 2021

Hyris Chalk Up Another Success Fighting COVID19, Providing Canadian Researchers and Medical Specialists With a New Test to Detect T-Cell Immune Response to SARS-CoV-2

Hyris developed a rapid T-Cell test to track patients' immunity levels to SARS-CoV-2 for global clinical and research use after having inked an exclusive licensing agreement with Duke-NUS Medical School. This new solution leverages the power of the renowned HYRIS bCUBE™ and the whole Hyris SystemTM. This disruptive platform enables genetic testing in any setting, at any time, with results available in real-time through its AI-powered platform. Read More

Press Release Oct 20, 2021

BillionToOne's Senior Vice President of Sales and Commercial Operations Named One of the Top 25 Women Leaders in Biotechnology of 2021

Press Release Oct 14, 2021

Hyris Brings to Market Worldwide a New Test That Can Quickly Detect the Body's T-Cell Immune Response to SARS-CoV-2, Thanks to a Partnership With Singapore's Duke-NUS Medical

Hyris developed a rapid T-cell test to track patients' immunity levels to SARS-CoV-2 for global clinical use after having inked an exclusive licensing agreement with Duke-NUS Medical School. This new solution leverages the Hyris SystemTM, a proprietary platform that enables genetic testing in any setting, at any time, with results available in real-time through its AI-powered platform. Read More

Press Release Oct 13, 2021

Ethical Releases Zoom Connector for Endpoint Adjudication Meetings

The eAdjudication® electronic endpoint adjudication platform is upgraded with an innovative Zoom connector that allows it to streamline the management of endpoint adjudication meetings, and safely and conveniently file meeting recordings and transcriptions within the platform. Read More

Press Release Oct 9, 2021

Nuvi Global published scientific studies supporting that the all-natural supplement Stemforte Plus, helps release adult stem cells and activate telomerase activity

Press Release Oct 7, 2021

United Health Products Provides Business Update

Press Release Sep 30, 2021

Pro-ficiency Selected as Participant in DPharm Idol Disrupt

Pro-ficiency was selected as a participant in the DPharm Idol Disrupt program, hosted at the Disruptive Innovations conference September 28-29, 2021. Read More

Press Release Sep 28, 2021

OmeCare and LifeSite Announce COVID-19 Testing Solution Partnership

The partnership provides a turnkey approach for workplaces, schools, major conventions, and other group events looking to ensure safety and meet governmental mandates for students, staff, employees, and event participants. Read More

Press Release Sep 20, 2021

NEMA Research Inc. Named to Short-List of Citeline Awards for 2021 Nominated for Excellence in Innovation and Response to COVID-19

Press Release Sep 14, 2021

The Electronic Endpoint Adjudication Platform eAdjudication® Improves DICOM Images Central Reading and Adjudication With DICOM/PACS Integration

The new DICOM / PACS extension to the eAdjudication® electronic endpoint adjudication software brings on board the Orthanc server and a fully-equipped DICOM image viewer. This comprehensive solution facilitates the acquisition, storage, transmission and display of DICOM images for Expert Committees. Read More

Press Release Sep 14, 2021

The Hyris System™ Detects SARS-CoV-2, Including Recently Emerged Variants of Concerns.

As new mutations of SARS-CoV-2 keep spreading worldwide, Hyris keeps monitoring its test kits effectiveness, performing routine analysis of SARS-CoV-2 variants to safeguard public health and the product's quality by assessing the potential impact of new strains on sensitivity and specificity. Read More